Schindler Holding AG
Schindler Holding AG
- ISIN: CH0024638212
- Land: Schweiz
Nachricht vom 24.08.2021 | 07:00
Schindler wins Bangalore Metro project
EQS Group-News: Schindler Holding AG
/ Key word(s): Contract
Schindler has been selected to deliver and install 180 escalators for two new routes of the Bangalore Metro Rail Corporation Ltd's Phase 2 project. The project will integrate the metro network with Bangalore's other urban transport systems, and eventually will connect the city's tech hub with Bangalore International Airport.
Bangalore, India's third-largest city, is well-known as a global tech hub. The Phase 2 project, which is set to be completed by 2026, will promote public transport to Bangalore's Information Technology (IT) district and is intended to ease the city's traffic congestion. Implementation has been divided into different elevated reach extensions and underground sections.
The project for which Schindler has been selected includes 140 escalators for the extension that will serve as the new Yellow Line route connecting Bangalore with Electronic City - one of India's largest IT industrial parks. In addition, Schindler will deliver and install 40 escalators for the new Pink Line north-south route through the city. The new stations will be able to transport an addi-tional 370,000 passengers a day.
'We're proud to be supporting a project of this magnitude that is bound to improve quality of life in Bangalore. Our technology will help the people of Bangalore navigate the city's expansive public transport network in a reliable, safe, efficient, and comfortable manner,' said Jujudhan Jena, Member of Schindler's Executive Committee responsible for Asia Pacific. 'I'm honored that we will play a vital role in forming the beating heart of Bangalore's metro system.'
Carolyn Pike | Head of Media Relations
Phone +41 41 445 32 98 | Mobile +41 79 195 27 81
|Company:||Schindler Holding AG|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1228398|
|End of News||EQS Group News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
04. Dezember 07:00 Einstiegschance voraus! Dieser Hot-Stock plant mit dem "Netflix für ...
04. Dezember 07:15 Bitcoin & Co: Brutaler Abverkauf – ist die Party jetzt vorbei?
04. Dezember 08:00 Top-Tipp Derivate: Luxus in der Warteschleife
04. Dezember 08:05 China-Aktien, Bitcoin & Co: Risiko-Assets werden verkauft
04. Dezember 08:45 Deutsche Telekom: 50 Prozent Potenzial - wann gelingt die Trendwende?
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021